45
Swep Bio raises $2.5M in first capital round under Reg D 506(b)
Company raise · Raising · SCARSDALE, NY · Form D filed 2026-10-29 · Follow Swep Bio, Inc. →
Swep Bio, a Delaware biotech corporation incorporated in 2026, is raising up to $5M and has sold $2.5M to date. The company is based in Scarsdale, NY and filed its first Form D on October 29, 2026.
Note: Company incorporated in 2026 and filed first Form D same year; verify operational status and use of proceeds.
First raise on EDGARother
How this compares
- Among 1,696 fund launches filed from NY in the same window it is larger than 50%; the NY median is $5M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| Goran Mikael Dolsten | Executive Officer, Director |
| Karl Erik Emanuel Berglund | Executive Officer, Director |
| Lovisa Backemar | Director |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Goran Mikael Dolsten, Secretary.
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.